Prospect Bio Funding
Prospect Bio is active in the following markets / industries: synthetic biology, chemicals, bioinformatics and renewable tech. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on November 1, 2016.
Investors of Prospect Bio
Illumina
Develops tools for DNA, RNA, and protein analysis for disease research
Rounds
S
Stanford-StartX Fund
Fund for StartX Founders
Rounds
S
GVA LaunchGurus
Rounds
S
Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
S
OS Fund
Rounds
S
Pallasite Ventures
Early Stage Capital
Rounds
S
Seed-stage investor and marketing exec passionate about consumer experiences. Previously partner at 500 Startups, CMO at Albert, Ring, Viddy; growth lead at Hulu. Haas MBA, Caltech MS.
500 Global is a venture capital firm that has invested in 2500+ cos across 77 countries
Rounds
S
Illumina Accelerator
Genomics Startup Accelerator in SF & Cambridge, UK